U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 5,937 records

Showing results for "stimulants".

  1. Ideas to Innovation: Stimulating Collaborations in the Application of Resilience Engineering to Healthcare. | PSNet

    psnet.ahrq.gov/issue/ideas-innovation-stimulating-collaborations-application-resilience-engineering-healthcare
    April 24, 2013 - Audiovisual Slideset Published April 24, 2013 Ideas to Innovation: Stimulating Collaborations in the Application of Resilience Engineering to Healthcare. Medstar Healthcare; University-Industry Demonstration Partnership;…

  2. Enabling Electronic Prescribing and Enhanced Management of Controlled Medications (pdf file)

    digital.ahrq.gov/sites/default/files/docs/activity/2011_017157_carrow_pdf_3.pdf
    January 01, 2011 - electronic prescribing (e-prescribing) to cover federally-controlled substances (e.g., narcotics, stimulants

  3. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  4. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  5. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  6. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  7. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  8. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  9. Section 5: Evidence, Attachment 1: AAP Guideline Evidence (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-1.pdf
    January 01, 2009 - results of the Multimodal Therapy of ADHD (MTA) study have identified a more persistent effect of stimulants … An uncommon additional significant adverse effect of stimulants is the occurrence of hallucinations

  10. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.cpsi.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  11. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.innovations.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  12. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.qualitymeasures.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  13. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.talkingquality.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  14. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.monahrq.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  15. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.healthcare411.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  16. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    www.cahps.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  17. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    ahrqpubs.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  18. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    talkingquality.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  19. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    patientregistry.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants

  20. Predischarge Antibiotics Review Associated With Lower Antibiotic Overuse | Agency for Healthcare Research and Quality

    healthcare411.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

ecareplan.ahrq.gov (1341)

psnet.ahrq.gov (742)

effectivehealthcare.ahrq.gov (547)

www.ahrq.gov (500)

cmext.ahrq.gov (432)

ce.effectivehealthcare.ahrq.gov (298)

hcup-us.ahrq.gov (211)

www.qualitymeasures.ahrq.gov (163)

digital.ahrq.gov (158)

srdr.ahrq.gov (143)

www.talkingquality.ahrq.gov (122)

www.uspreventiveservicestaskforce.org (119)

www.innovations.ahrq.gov (116)

www.monahrq.ahrq.gov (115)

www.healthcare411.ahrq.gov (113)

www.cahps.ahrq.gov (111)

www.cpsi.ahrq.gov (87)

pcmh.ahrq.gov (75)

pbrn.ahrq.gov (70)

monahrq.ahrq.gov (62)

cahps.ahrq.gov (61)

healthcare411.ahrq.gov (60)

patientregistry.ahrq.gov (54)

talkingquality.ahrq.gov (54)

ahrqpubs.ahrq.gov (52)

preventiveservices.ahrq.gov (43)

teamstepps.ahrq.gov (39)

meps.ahrq.gov (25)

qualityindicators.ahrq.gov (6)

srdrplus.ahrq.gov (5)

cds.ahrq.gov (4)

cdsic.ahrq.gov (3)

datatools.ahrq.gov (2)

hcupnet.ahrq.gov (2)

covid-acts.ahrq.gov (1)

pso.ahrq.gov (1)